About this trial
Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered Endoscopic Linear Cutting Staplers and Disposable Endoscopic Linear Cutting Staplers manufactured by Ningbo Verykind Medical Device Co., Ltd. have marketed in many countries or area for many years. The investigational devices are intended for transection, resection, and/or creation of anastomoses. The instruments have application in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures.
In order to confirm the safety and performance of the products, as well as the continued safety and clinical performance of the implant (the staple) during the clinical follow-up period, monitor the identified side-effects, contraindications and identify previously unknown side-effects, and ensure the continued acceptability of the benefit-risk ratio, Investigators proactively collect and evaluate clinical data from different regions, including of Italy, Brazil and Chile, where the device has been marketed, and conduct PMCF studies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age≥18 years old, gender unlimited;
The surgery type shall be open or endoscopic surgery;
The departments of surgical procedures: general, gynecologic, urologic and thoracic surgical procedures;
Investigational devices listed in this PMCF plan must be used during surgical procedures.
Disqualifiers
Patients with surgical contraindications to the product, e.g. use the instruments on large arteries, on ischemic or necrotic tissue, use the device on tissues with a compression thickness out of the device range;
Concomitant with similar devices (staplers/reloads/cartridges, etc.) for resection, transection and anastomosis of surgical organ or tissues;
The operation record is incomplete, and the information related to the main indicators cannot be extracted.
Trial population
Cartridges of Disposable Endoscopic Linear Cutting Staplers are intended for transection, resection, and/or creation of anastomoses. The instruments are applied in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures. They must be used in combination with Disposable Powered Endoscopic Linear Cutting Staplers or Disposable Endoscopic Linear Cutting Staplers manufactured by the Company.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered
DeviceInvestigational devices encompassing all models of the Cartridges for Disposable Endoscopic Linear Cutting Staplers, as well as Staplers utilized in conjunction with the Cartridges specified in the Study Plan (Plan number: WEKD-QS-PMCF).
Treatment groups
Trial outcomes
Primary outcomes
Anastomosis success rate
According to surgical records and inpatient medical records, no reoperation in situ is defined as successful anastomosis.
Secondary outcomes
Anastomotic bleeding rate
Anastomotic leakage rate
Anastomotic stenosis rate
Other outcomes
Surgical time
Intraoperative bleeding
Intraoperative conversion (due to device reasons)
Length of hospitalization
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.